Simulations Plus (NASDAQ:SLP) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a research note issued to investors on Friday.
Separately, Zacks Investment Research upgraded shares of Simulations Plus from a “sell” rating to a “hold” rating in a report on Wednesday.
Shares of Simulations Plus (NASDAQ SLP) traded up $0.45 on Friday, reaching $16.55. 34,665 shares of the company were exchanged, compared to its average volume of 54,884. The firm has a market capitalization of $294.19, a P/E ratio of 47.29 and a beta of -0.76. Simulations Plus has a fifty-two week low of $9.45 and a fifty-two week high of $17.45.
In other Simulations Plus news, CEO Walter S. Woltosz sold 18,500 shares of the company’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $15.78, for a total value of $291,930.00. Following the transaction, the chief executive officer now directly owns 5,610,916 shares in the company, valued at $88,540,254.48. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Over the last 90 days, insiders have sold 55,500 shares of company stock worth $893,180. 33.45% of the stock is owned by corporate insiders.
Several large investors have recently added to or reduced their stakes in the business. Bank of Montreal Can acquired a new position in shares of Simulations Plus in the fourth quarter valued at about $104,000. The Manufacturers Life Insurance Company grew its stake in shares of Simulations Plus by 13.8% in the second quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock valued at $110,000 after acquiring an additional 1,085 shares in the last quarter. OxFORD Asset Management LLP acquired a new position in shares of Simulations Plus in the second quarter valued at about $126,000. Rhumbline Advisers acquired a new position in shares of Simulations Plus in the second quarter valued at about $126,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Simulations Plus in the second quarter valued at about $143,000. Hedge funds and other institutional investors own 33.45% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was first reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2018/01/27/simulations-plus-slp-cut-to-sell-at-bidaskclub.html.
About Simulations Plus
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.